Abstract: A computational analysis on the CH/ interactions in a group of 49 therapeutic proteins was investigated. A total of 77 CH/ interactions were observed. The donor atom contribution to CH/ interactions was mainly from aromatic residues. Long-range CH/ interactions are the predominant type of interactions in therapeutic proteins data set. The secondary structure preference, solvent accessibility and stabilization centers of these of CH/ interacting residues were estimated. 73% of the donor residues and 65% of the acceptor residues were highly conserved.
INTRODUCTION
The importance of conventional interactions such as, hydrogen bonds, salt bridges hydrophobicity and other standard interactions in the stabilization of secondary structures [1] , protein folding and stability [2, 3] are well established [4] [5] [6] . With the recent advances in computational biology one can assess the effect of non-standard interactions on the stability of protein tertiary structure. Among the nonconventional interactions, there is little data on the contribution of CH/ interactions to protein stability. The exothermic dissolution of benzene and similiar compounds ( -electron system: proton acceptor) in chloroform (C-H group: proton donor) was perhaps the origin of an interaction, now known as CH/ interactions, a form of weak hydrogen bond [7] . In 1957, Reeves and Schneider showed by NMR that this interaction was a type of H-bond [8] . Since then, CH/ interactions have been described in a vast number of small molecule systems from simple olefinic and aromatic compounds to complicated clathrates and inclusion complexes. In 1998 Nishio et al. published excellent treatise of these observations [9] . In this way CH/ interactions are gradually gaining a lot of importance.
The cases in which CH/ interactions have been described in proteins include the formation of complexes of proteins with special ligands or cofactors such as the heme group [9] , pyridoxal-5'-phosphate [10] , nucleotides [11, 12] , carbohydrates [13] and bound peptides [14] , or special geometric circumstances, for instance between neighboring side-chains around a cis peptide bond [15] . The importance of this interaction has also been recognized in the design of serine protease inhibitors [16, 17] . There are also recent reviews [18] [19] [20] and monographs [9] where the role of CH/ interactions in the structure of chemical and biological *Address correspondence to this author at the School of Biotechnology, Chemical and Biomedical Engineering, Bioinformatics Division, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India; Tel: +91 4162202522; Fax: +91 4162243092; E-mail: rsethumadhavan@vit.ac.in macromolecules are described. These interactions also play an important role in the interaction between protein and lipid membranes [11] .
These developments motivated us to study the relation between occurrences of CH/ interactions within the protein to the structural stability. To the best of the authors' knowledge, such interactions in therapeutic proteins, which include anticancer antibodies, such as rituximab, used for Bcell non-Hodgkin's lymphoma data set is not yet available. Hence, in this work an effort has been made to collect the information concerning CH/ interactions in the therapeutic proteins data set. In addition, we have chosen only one chain in the therapeutic proteins structure. These represent relatively simpler systems in which all the weaker interactions can be studied in the absence of the effects of a complex quaternary structure and the occurrence of redundancy in the data set. We emphasize that 21 therapeutic proteins in our data set showed a CH/ interactions and hence we accentuate that this investigation is very significant in the sense that, CH/ interactions in therapeutic proteins do play a major role in structural stability of these proteins. It is noteworthy to mention here, that our observations on the results of CH/ interactions was completely different with earlier report on RNA binding protein, in a sense that, only aromatic amino acids takes part in CH/ interactions in therapeutic proteins data set. Ours is the first report on computational investigation on the CH/ interactions in therapeutic proteins.
MATERIALS AND METHODS

Data Set
We have considered a set of 49 therapeutic proteins from the Protein Data Bank [21] for our investigation the details of which are given in Table 1 . According to the structural classification of proteins, 42% of this protein comes under alpha group, 29% comes under beta 11% comes under alpha and beta and remaining18% comes under small proteins in the therapeutic protein data set. 
CH/ Interactions
CH/ interactions are calculated using the program available for this purpose called HBAT [22] . The CH/ interactions considered here were between all possible donor C-H groups in protein structures (C -H, C ali -H and C aro -H) and between all side-chain systems (the aromatic rings of Phe, Tyr, Trp and His). The positions and geometry of donor and acceptor atom are shown in Fig. (1) . The donor group is represented as C-H and the acceptor is the system. The distances are usually measured from the centroid (M) ie, centre of the ring. P1 and P2 are distances from C and H, respectively, to M. P3 is the angle between vectors C-H and H-M while P4 is the angle between the CM and MN. Here N is a normal to the centre of the ring. The geometry is adapted from earlier work of babu [23] . The CH/ interaction types are represented by a two-letter code in which the first letter indicates the donor atom and the second the acceptor: M, S and S5 represent the main-chain atom, side-chain atom and side-chain atom in the five-membered aromatic ring, respectively. We classified the CH/ interactions into four types of CH/ interactions namely, main-chain to side-chain CH/ interactions (MS-CH/ ), main-chain to side-chain five member aromatic ring CH/ interactions (MS5-CH/ ), side-chain to sidechain CH/ interactions (SS-CH/ ) and side-chain to side-chain five member aromatic ring CH/ interactions (SS5-CH/ ) [23] .
Secondary Structure and Solvent Accessibility
Secondary structure and solvent accessibility are the two major intermediate steps to understand the structure and function of proteins. Hence a systematic analysis of each CH/ interaction forming residue was performed based on their location in different secondary structures of therapeutic proteins and their solvent accessibility. We obtained the information about secondary structures and solvent accessibility of the proteins using the program DSSP [24] . Solvent accessibility was divided into three classes, buried, partially buried and exposed indicating, respectively, the least, moderate and high accessibility of the amino acid residues to the solvent [25, 26] .
Sequential Distance
The CH/ interacting residues coming within a sphere of 8Å was computed as described earlier [27] [28] [29] . The residues coming within a sphere of 8Å was computed as described earlier [30] . For a given residue, the comparison of the surrounding residue is analyzed in terms of the location at the sequence level. The contribution from <±4 are treated as short-range contacts, >4 to <±20 as medium-range contacts and >20 are treated as long-range contacts [30] . This classification enables us to evaluate the contribution of shortrange, medium-range and long-range contacts in the formation of CH/ interactions.
Stabilization Centers
Stabilization centers are clusters of residues that are involved in medium or long-range interactions [31] . Residue (Table 1) clusters are identified in protein contact maps where an accumulation of long range interactions are observed. The residues in these cores are called stabilization center (SC) residues, referring to their suspected role in 3D structure stabilization, and are identified as follows. The sequence environment of each residue pair involved in a long range interaction is analyzed. For each such residue pair we locate two additional pairs, one in the N-terminal flanking tetrapeptide and one in the C-terminal tetrapeptide of the original interacting residue pair making the most long range interactions with each other. If the number of interactions of these two triplets, the central interacting residues plus the two additional ones, one on each flanking side is equal to or greater than seven of the possible nine contacts, then the two central residues are accepted as members of a SC. The stabilization centers for the CH/ interacting amino acid residues were computed using the SCide server [32] for computing the stabilization centers.
Conservation Score
We computed the conservation score of CH/ interacting amino acid residues in each protein using the ConSurf server [33] . This server computes the conservation based on the comparison of the sequence of a PDB chain with the proteins deposited in Swiss-Prot [34] and finds the ones that are homologous to the PDB sequence. The number of PSI-BLAST iterations and the E-value cutoff used in all similarity searches were 1 and 0.001, respectively. All the sequences that are evolutionarily related with each one of the proteins in the data set were used in the subsequent multiple alignments. Based on these protein sequence alignments the residues are classified into nine categories from highly variable to highly conserved. Residues with a score of 1 are considered highly variable and residues with a score of 9 are considered highly conserved.
Stabilizing Residues
Stabilizing residues were computed using the parameters such as surrounding hydrophobicity, long-range order, stabilization center and conservation score as described by Gromiha [35] . We used the server SRide [35] for this purpose. Conservation score of 6 is the cutoff value used to identify the stabilizing residues. Fig. (2) illustrates an SS-5-CH/ interaction in therapeutic protein PDB 1D 1BML (between Trp 685 (CE3) and His 586). The specific pair wise residue involved in CH/ interaction, their position and sequential distances for all the therapeutic proteins studied are given in Table 2 . We found that, in the therapeutic protein data set only aromatic amino acids involved in CH/ interaction. Probably C -H and C aro -H groups might have more specificity towards other non standard interactions like C-H….O interactions [36] . 82% interactions were SS-CH/ and 18% interactions were SS5-CH/ . The CH/ interactions forming residues distance with respect to its position of C-atom is shown in Fig. (3) . It was found that, majority 27% of the interactions were found between the residue distances in the range of 4.01 Å to 4.25 Å. The CH/ interactions forming residues distance with respect to its position of H-atom were shown in Fig. (4) . Of the total 77 interactions, the majority 39% of the interactions were found between the residue distances in the range of 3.76 Å to 4.00 Å. Atom vice contribution to CH/ interactions were studied in the data set. It was observed that, among the donor residues, majority 43% of the interactions from Phe, 31%of the interactions from Trp and remaining 26% of the interactions from Tyr. Among the acceptor residues, 34% of the interactions from Trp, 32% of the interactions from Phe, 18% of the interactions from His and 16% of the interactions from Tyr.
RESULTS
CH/ Interactions
Secondary Structure Preferences
The propensity of the amino acid residues to favor a particular conformation has been well documented. Such conformational preference is not only dependent on the amino acid alone but is also dependent on the local amino acid sequence. We analyzed the secondary structure preference of each amino acid, which participated in all the different types of CH/ interactions namely, SS-CH/ and SS5-CH/ interactions. The secondary structure preference of each of the amino acids involved in all the above said types of CH/ interactions were obtained using DSSP and the results are depicted in Table 3 . We found that, Phe, Trp preferred to be in coil, Tyr preferred to be in strand and His preferred to be in helix. Fig. (2) . Pymol view of CH/ interactions in 1BML. 1PGG   Y64  Y355  F356  F220  F407  F292  W100  F210  F407  F395  F200  F200  Y404   CE1  CE1  CD2  CE1  CE2  CE2  CD1  CE2  CD2  CE2  CD2  CE2  CD1   H43  H90  W100  Y147  F200  H204  F356  Y385  F395  Y404  F426  F426 
No interactions; Dseq: Sequential distance.
Solvent Accessibility
The relation between the amino acid residues in CH/ interactions and solvent accessibility is depicted in Fig. (5) .
The solvent accessibility of amino acid residues has been categorized as buried, partially buried and exposed [25, 26] . We found that, all the aromatic residues such as Phe, Tyr, Trp and His residues were in the buried regions. This Parenthesis value shows frequency of secondary structure of the residues in the whole data set.
observation is quite reasonable in the sense that, the aromatic residues are in principle, non polar residues, and tend to be buried. According to Manfred S. Weiss et al. [37] , CH/ interactions involving aromatic residues either as donor or as acceptor groups are found mostly in the interior of the protein and tend to be buried in nature. These might be one of the reasons for their nature of solvent accessibility.
Sequential Separation
The contribution of CH/ interactions in therapeutic proteins could define either the local or the global stability of the proteins. Therefore, there is a need to evaluate the contribution of inter-residual CH/ interactions. The contribution from <±4 are treated as short-range contacts, >4 to <±20 as medium-range contacts and >20 are treated as long-range contacts [30] . This classification enables us to evaluate the contribution of short-range, medium-range and long-range contacts in the formation of CH/ interactions. The sequential distance between residues that contributed donor and acceptor atoms to inter-residue CH/ interactions were calculated. 50%, 29% and 21% of inter-residue CH/ interactions were found to be long-range, medium-range and short-range interactions respectively. Our results are consistent with RNA binding protein reported by our group earlier [38] .
Stabilization Centers
We used the SCide server for computing the stabilization centers in the therapeutic proteins data ser. We found that 20% of the amino acid residues that contribute donor atoms to CH/ interactions had one or more stabilization centers in addition to their contribution to CH/ interactions and similarly 23% of the amino acid residues that contribute acceptor atoms to CH/ interactions had one or more stabilization centers in addition to their contribution to CH/ interactions. From this we infer that, these residues might contribute additional stability to the therapeutic proteins in addition to their participation in CH/ interactions.
Conservation Score
We used the ConSurf server to compute the conservation score of amino acid residues involved in CH/ interactions in therapeutic proteins, and the results are shown in Fig. (6) . 21% of the amino acid residues that contributed donor atoms in CH/ interactions had the highest conservation score of 9, while 52% of the amino acid residues had a conservation score, in the range of 6-8. Thus, 73% of the donor amino acid residues had a high conservation score. In the case of amino acid residues, that contributed acceptor atoms in CH/ interactions, 12% of the acceptor amino acid residues had the highest conservation score of 9, while 53% of the amino acid residues had a conservation score, in the range of 6-8. Thus, 65% of the acceptor amino acid residues had a high conservation score. From these observations, we were able to infer that, most of the amino acid residues involved in CH/ interactions might be conserved in therapeutic proteins.
Stabilizing Residues
We thought it would be useful to identify any patterns of correlation between the CH/ interactions in a given therapeutic protein and the theoretically predicted stabilizing residues [35] . Stabilizing residues were computed using the parameters such as surrounding hydrophobicity, long-range order, stabilization center and conservation score. We used the server SRide for this purpose. None of the stabilizing residues are involved in the CH/ interactions. Hence apart from the stabilizing residues, the CH/ interactions may play a big role in the stability of the therapeutic proteins.
DISCUSSION
CH/ interactions have been identified to occur in 43% of therapeutic proteins in the data set. Unlike the involvement of main chain CH/ interactions in RNA binding protein, therapeutic protein CH/ interactions appear to occur relatively frequently between side-chains residues. The most prominent representatives are the interactions between aromatic C-H donor groups and aromatic -acceptors. The geometric parameters calculated for these interactions suggest that CH/ interactions can be classified as weak Hbonds, and occur mainly in the distances greater than 4.00Å and 3.76Å from C atom and H atom respectively in the data set. The atom vice contribution to CH/ interactions shows that, Phe has the highest occurrence among the donor residues and Trp contribution higher than the other aromatic amino acid in the acceptor side. CH/ interactions involving aromatic -systems as a donor or acceptor groups are generally found closer to the center of the protein and hence is buried in nature. The secondary structure preference analysis of CH/ interacting residues showed that Phe and Trp occurred most frequently in coil segments, while Tyr and His, respectively, occurred more in strand and helix segments. Thus, therapeutic proteins are therefore confronted with a very diverse array of surfaces resulting in the differences of amino acids to a particular secondary structure conformation. Long-range CH/ interactions are the predominant type of interactions in therapeutic proteins. The contribution of the medium-range and short-range interactions is comparatively less in the two types of interresidue CH/ interactions studied. These results indicate that, long-range CH/ interactions contribute significantly to the global conformational stability of therapeutic proteins. Significant percentage of both donor and acceptor residues involved in CH/ interactions had one or more stabilization centers. From this we infer that, these residues might contribute additional stability to the therapeutic proteins in addition to their participation in CH/ interactions. None of the stabilizing residues are involved in the CH/ interactions. Hence apart from the stabilizing residues, the CH/ interactions may play a big role in the stability of the therapeutic proteins. 73% of the donor amino acid residues and 65% of the acceptor amino acid residues had a high conservation score. It might be due to their involvement in CH/ interactions and to the stability or the function of the protein. We hope this scrutiny will assist structural biologist and medicinal chemist to design better and safer drugs.
CONCLUSION
In conclusion, therapeutic proteins are stabilized by CH/ interactions. Aromatic amino acids contribute extensively to this CH/ interactions in therapeutic proteins data set. Majority of the interacting aromatic residues are located interior of the protein surface and tends to be buried in nature. Therapeutic proteins are confronted with a very diverse array of surfaces resulting in the differences of amino acids to a particular secondary structure conformation. The resulting high conservation score might be due to their involvement in the stability of therapeutic proteins. Thus from the cumulative analysis, we can infer that, the CH/ interactions do contribute significantly to the stability of therapeutic proteins based on our data. 
